PDL BioPharma, Inc. Operating Lease Right-of-Use Assets
PDL BioPharma, Inc. had Operating Lease Right-of-Use Assets of $3.30 million as of 2020-09-01, per its 10-Q filed 2020-11-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2021-03-29
- 2020-09-01: Operating Lease, Right-of-Use Asset $3.30M.
- 2019-12-31: Operating Lease, Right-of-Use Asset $1.36M; Operating Lease, Right-of-Use Asset as first filed $1.64M.
- 2019-03-31: Operating Lease, Right-of-Use Asset $1.88M.
- 2019-01-02: Operating Lease, Right-of-Use Asset $2.10M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2020-09-01 | $3.30M 10-Q · filed 2020-11-13 | |
| 2019-12-31 | $1.36M 10-K · filed 2021-03-29 | $1.64M 10-K · filed 2020-03-11 |
| 2019-03-31 | $1.88M 10-Q · filed 2019-05-09 | |
| 2019-01-02 | $2.10M 10-Q · filed 2019-11-06 | |
| 2019-01-01 | $2.10M 10-K · filed 2021-03-29 |